Project Details
Description
International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A treated 15 months
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/15 → 11/30/19 |
Funding
- PHARNEXT
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.